Polarean Highlights New CHEST Journal Study Demonstrating Xenon MRI Predicts Cystic Fibrosis Exacerbations

The study, titled “Structural and Functional Pulmonary MRI to Predict Pulmonary Exacerbations in Cystic Fibrosis,” analyzed imaging and clinical data from 106 individuals with CF who were imaged and ...
ascopubs.org

DCE-MRI perfusion imaging of head and neck squamous cell carcinoma nodal metastasis: Identifying radioresistance and the distant metastatic phenotyp

Use of restaging primary site biopsy to optimize selection of primary therapy in high stage (III/IV) squamous cancer No significant financial relationships to disclose. This is an ASCO Meeting ...
Medscape

Novel PET Tracer for Perfusion Imaging: What's the Potential?

The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...
ascopubs.org

The correlation of perfusion-weighted MRI with VEGF in resected pancreatic cancer

High complete response (CR) rate in patients (pts) with esophageal carcinoma (EC) undergoing neoadjuvant combination of docetaxel and cisplatin (DC) ± cetuximab(DCE) chemoradiation therapy—a ...
TCTMD

FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades

A new radioactive tracer for positron emission tomography (PET) myocardial perfusion imaging will soon be available in the United States, and it’s expected to facilitate substantial growth in such ...
Business Insider

Kent Imaging Revolutionizes Perfusion Imaging with Their FDA Cleared KD203

CALGARY, Oct. 19, 2017 /CNW/ - Kent Imaging, a leading provider of near infrared imaging solutions, announced today that the U.S. Food and Drug Administration (FDA) has cleared their multispectral ...